Palvella Therapeutics to Host Webcast to Introduce New QTORIN™ Program
Globe Newswire•18/11/2026•17:00 ET
0
Key Highlights
- ➤Third QTORIN™ platform product candidate to be announced tomorrow
- ➤Live webcast scheduled November 19, 2026, at 8:30 a.m. ET
- ➤QTORIN™ rapamycin targets three rare vascular and skin conditions
- ➤QTORIN™ pitavastatin targets disseminated superficial actinic porokeratosis
Third product candidate from Palvella’s QTORIN™ platform to be announced
Live audiovisual webcast to take place tomorrow, Thursday, November 19, 2026, at 8:30 a.m. ET
Get started
Create a free account to read the full story.
